Cancer Genetics and Epigenetics 2024, Vol.12, No.5, 254-269 http://medscipublisher.com/index.php/cge 268 Nagrath S., Sequist L.V., Maheswaran S., Bell D.W., Irimia D., Ulkus L., Smith M.R., Kwak E.L., Digumarthy S., Muzikansky A., Ryan P., Balis U.J., Tompkins R.G., Haber D.A., and Toner M., 2007, Isolation of rare circulating tumour cells in cancer patients by microchip technology, Nature, 450(7173): 1235-1239. https://doi.org/10.1038/nature06385 PMID: 18097410 PMCID: PMC3090667 Pan R.J., Hong H.J., Sun J., Yu C.R., Liu H.S., Li P.Y., and Zheng M.H., 2021, Detection and clinical value of circulating tumor cells as an assisted prognostic marker in colorectal cancer patients, Cancer Management and Research, 13: 4567-4578. https://doi.org/10.2147/CMAR.S300554 PMID: 34135633 PMCID: PMC8197664 Pantel K., and Speicher M.R., 2016, The biology of circulating tumor cells, Oncogene, 35(10): 1216-1224. https://doi.org/10.1038/onc.2015.192 Park J.M., Lee J.Y., Lee J.G., Jeong H., Oh J.M., Kim Y.J., Park D., Kim M.S, Lee H.J., Oh J.H., Lee S.S., Lee W.Y., and Huh N., 2012, Highly efficient assay of circulating tumor cells by selective sedimentation with a density gradient medium and microfiltration from whole blood, Analytical Chemistry, 84(17): 7400-7407. https://doi.org/10.1021/ac3011704 PMID: 22881997 Paterlini-Bréchot P., and Benali N.L., 2007, Circulating tumor cells (CTC) detection: clinical impact and future directions, Cancer Letters, 253(2): 180-204 . https://doi.org/10.1016/J.CANLET.2006.12.014 PMID: 17314005 Pawlikowska P., Faugeroux V., Oulhen M., Aberlenc A., Tayoun T., Pailler E., and Farace F., 2019, Circulating tumor cells (CTCs) for the noninvasive monitoring and personalization of non-small cell lung cancer (NSCLC) therapies, Journal of Thoracic Disease, 11(Suppl 1): S45-S56. https://doi.org/10.21037/jtd.2018.12.80 PMID: 30775027 PMCID: PMC6353742 Pereira-Veiga T., Schneegans S., Pantel K., and Wikman H., 2022, Circulating tumor cell-blood cell crosstalk: biology and clinical relevance, Cell Reports, 40(9): 111298. https://doi.org/10.1016/j.celrep.2022.111298 PMID: 36044866 Qi L.N., Xiang B.D., Wu F.X., Ye J.Z., Zhong J.H., Wang Y.Y., Chen Y.S., Chen Z.S., Ma L., Chen J., Gong W.F., Han Z.G., Lu Y., Shang J.J., and Li L.Q., 2018, Circulating tumor cells undergoing emt provide a metric for diagnosis and prognosis of patients with hepatocellular carcinoma, Cancer Research, 78(16): 4731-4744. https://doi.org/10.1158/0008-5472.CAN-17-2459 PMID: 29915159 Qian W.Y., Zhang Y., and Chen W.Q., 2015, Capturing cancer: emerging microfluidic technologies for the capture and characterization of circulating tumor cells, Small, 11(32): 3850-3872. https://doi.org/10.1002/smll.201403658 PMID: 25993898 Ring A., Nguyen-Sträuli B.D., Wicki A., and Aceto N., 2023, Biology, vulnerabilities and clinical applications of circulating tumour cells, Nature Reviews, Cancer, 23(2): 95-111. https://doi.org/10.1038/s41568-022-00536-4 PMID: 36494603 PMCID: PMC9734934 Shahjehan F., Kamatham S., and Kasi P., 2019, Role of circulating tumor DNA in gastrointestinal cancers: update from abstracts and sessions at ASCO 2018, Frontiers in Oncology, 9: 358. https://doi.org/10.3389/fonc.2019.00358 PMID: 31139561 PMCID: PMC6519295 Stoecklein N.H., Oles J., Franken A., Neubauer H., Terstappen L.W.M.M., and Neves R.P.L., 2023, Clinical application of circulating tumor cells, Medizinische Genetik, 35(4): 237-250. https://doi.org/10.1515/medgen-2023-2056 Sundling K.E., and Lowe A.C., 2019, Circulating tumor cells: overview and opportunities in cytology, Advances in Anatomic Pathology, 26(1): 56-63. https://doi.org/10.1097/PAP.0000000000000217 PMID: 30325755 Tan Y., and Wu H., 2017, The significant prognostic value of circulating tumor cells in colorectal cancer: a systematic review and meta-analysis, Current problems in cancer, 42(1): 95-106. https://doi.org/10.1016/j.currproblcancer.2017.11.002 Tie J., Cohen J.D., Wang Y., Christie M., Simons K., Lee M., Wong R., Kosmider S., Ananda S., Mckendrick J., Lee B., Cho J.H., Faragher I., Jones I.T., Ptak J., Schaeffer M.J., Silliman N., Dobbyn L., Li L., Tomasetti C., Papadopoulos N., Kinzler K.W., Vogelstein B., and Gibbs P., 2019, Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer, JAMA Oncology, 5(12): 1710-1717. https://doi.org/10.1001/jamaoncol.2019.3616 PMID: 31621801 PMCID: PMC6802034
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==